Picard Medical Reports Second Quarter 2026 Financial Results
Picard Medical reported Q2 revenue of $3.0 million, up 39% year-over-year, with gross profit turning positive to $0.6 million. Net loss narrowed 16% to $5.7 million, but the company required a 1-for-50 reverse stock split effective July 31 to maintain NYSE American listing compliance.
Key figures
- Revenue
- 3000000
- Revenue Yoy
- 39%
- Net loss
- 5700000
- Ytd revenue
- 4100000
- Gross margin
- 20.9%
- Reverse split ratio
- 1-for-50
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.